Clinical Trials Logo

Heart Defects, Congenital clinical trials

View clinical trials related to Heart Defects, Congenital.

Filter by:

NCT ID: NCT00757510 Terminated - Clinical trials for Congenital Heart Disease

Congenital Heart Disease Research Registry

CHDRR
Start date: January 2008
Phase: N/A
Study type: Observational

The Congenital Heart Disease Research Registry (CHDRR) is a program dedicated to understanding the etiology and improving the treatment of Congenital Heart Disease (CHD). This Registry will act as a central coordinating center for recruiting subjects with CHD and will provide infrastructure and guidelines for researchers studying the causes and treatment of CHD. Investigators working directly with the Registry will have access to biological, demographic and phenotype data from a significant pool of participants with CHD.

NCT ID: NCT00751712 Completed - Clinical trials for Congenital Heart Disease

Cerebral Oximetric Monitoring of the Posterior Circulation

CerebralOx
Start date: May 2006
Phase: N/A
Study type: Observational

One known risk of pediatric heart surgery is the possibility for brain damage. This problem results from a lack of oxygen rich blood flow to the brain during surgery. In order to provide the patient's brain with blood during this operation, selective cerebral perfusion is sometimes used. This technique allows for adequate blood flow to the brain, and is monitored using special sticker sensors. The sensors are applied to the patient's forehead, and a corresponding monitor indicates oxygen levels in the front part of the brain. The goal of this study is to find out if these same stickers can be applied to the base of the skull to measure cerebral oxygenation at the back of the brain, and to determine if the back of the brain is adequately oxygenated during selective cerebral perfusion in patients undergoing complex aortic arch reconstruction.

NCT ID: NCT00740870 Completed - Clinical trials for Congenital Heart Defects

Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort

Start date: January 2007
Phase: N/A
Study type: Interventional

The primary objective is to confirm the long-term functionality of implantation of the Medtronic Melody TPV at 5 years is no worse than the historical control established through literature review. The secondary objectives are to evaluate long-term functionality at 10 years and to assess safety, procedural success, and clinical utility of transcatheter implantation of the Melody TPV.

NCT ID: NCT00713635 Completed - Clinical trials for Congenital Heart Disease

Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome

Start date: December 2010
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the prenatal impact of abnormal cardiac structure on neurodevelopmental outcomes in children with congenital heart disease.

NCT ID: NCT00708409 Enrolling by invitation - Clinical trials for Aortic Valve Disease

Long-Term Follow-up After the Autograft Aortic Valve Procedure (Ross Operation)

Start date: January 2001
Phase: N/A
Study type: Observational

With the current knowledge of aortic valve replacement modalities, no specific recommendations can be given and the decision for a particular prosthesis or procedure is rather arbitrarily. The investigators hypothesize that the autograft procedure according to Ross is superior in terms of hemodynamic (especially regression of left ventricular hypertrophy) and major adverse valve related events even in a long-term course

NCT ID: NCT00705913 Terminated - Clinical trials for Aortic Valve Disease

Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna

Start date: June 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.

NCT ID: NCT00693498 Completed - Clinical trials for Congenital Heart Disease

Washed Versus Standard Blood Cell Transfusions in Pediatric Open Heart Surgery

Start date: July 2008
Phase: N/A
Study type: Interventional

Background: Children having open heart surgery to repair congenital heart defects demonstrate a large inflammatory response to the heart-lung machine and to surgery itself. In general, the more intense their inflammatory response, the more critically ill they are following surgery. These children routinely require large numbers of blood transfusions during and following surgery as part of their medical management that adds to their heightened inflammatory state. Whether additional steps to "wash" blood products and remove the substances contributing to post-transfusion inflammation will limit this response, and improve the health of children following open heart surgery, remains to be studied. Aims: To compare the inflammatory response in children having open heart surgery who receive washed versus unwashed blood transfusions. Methods: We will randomly assign children having open heart surgery to one of two groups: group 1 will receive blood transfusions per the current standard of care, group 2 will receive blood transfusions that have been washed in addition to the current standard of care. We will then use blood tests to measure the inflammatory response in children of each group. We will compare the results to determine whether washing blood transfusions decreases inflammation and post-operative complications following open heart surgery. Conclusion: We believe that washing blood transfusions given to children following open heart surgery will decrease their inflammatory response and improve their overall health.

NCT ID: NCT00677638 Active, not recruiting - Clinical trials for Aortic Valve Disease

Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease

Start date: June 2008
Phase: N/A
Study type: Interventional

A prospective single arm study evaluating feasibility and safety of a catheter-based transapical implantation of the Ventor Embracer™ aortic valve bioprosthesis in patients with severe aortic valve disease, specifically aortic stenosis, who are at elevated risk for standard surgical valve replacement.

NCT ID: NCT00668824 Recruiting - Clinical trials for Congenital Heart Disease

Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist

CHD Vasovist
Start date: March 2007
Phase: Phase 4
Study type: Interventional

Magnetic Resonance Imaging (MRI) is an effective and radiation free method of diagnosing Congenital Heart Disease (CHD). MRI works by taking images of the anatomy and physiology. These images also provide information on the hearts function and blood flow. The clarity of these images is enhanced by the use of contrast agents (dyes). However these agents only stay in the blood vessels for a short time and therefore limit the time in which the better quality images can be obtained. This study aims to determine whether MRI using Vasovist (a dye that stays in the vessels for a prolonged period of time) can improve the diagnosis of Congenital Heart Disease (CHD) by allowing more areas to be imaged and the improved assessment of various parameters (anatomy, volumes, flow) as well as vastly improving image quality.

NCT ID: NCT00665301 Completed - Clinical trials for Congestive Heart Failure

Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000

Start date: March 2008
Phase: N/A
Study type: Observational

The purpose of this study is to compare cardiac output results obtained using the thermodilution push technique with the Pulmonary Arterial Catheter (PAC) to the predicted cardiac output results obtained from the non-invasive FloWave™ 1000 device.